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ORIGINAL ARTICLE
Development of a Full-Thickness Human Skin
Equivalent In Vitro Model Derived from
TERT-Immortalized Keratinocytes and Fibroblasts
Christianne M.A. Reijnders, PhD,1 Amanda van Lier, MSc,1 Sanne Roffel, Ing,1
Duco Kramer, Ing,2 Rik J. Scheper, PhD,3 and Susan Gibbs, PhD1,4
Currently, human skin equivalents (HSEs) used for in vitro assays (e.g., for wound healing) make use of
primary human skin cells. Limitations of primary keratinocytes and fibroblasts include availability of donor skin
and donor variation. The use of physiologically relevant cell lines could solve these limitations. The aim was to
develop a fully differentiated HSE constructed entirely from human skin cell lines, which could be applied for
in vitro wound-healing assays. Skin equivalents were constructed from human TERT-immortalized keratino-
cytes and fibroblasts (TERT-HSE) and compared with native skin and primary HSEs. HSEs were characterized
by hematoxylin–eosin and immunohistochemical stainings with markers for epidermal proliferation and dif-
ferentiation, basement membrane (BM), fibroblasts, and the extracellular matrix (ECM). Ultrastructure was
determined with electron microscopy. To test the functionality of the TERT-HSE, burn and cold injuries were
applied, followed by immunohistochemical stainings, measurement of reepithelialization, and determination of
secreted wound-healing mediators. The TERT-HSE was composed of a fully differentiated epidermis and a
fibroblast-populated dermis comparable to native skin and primary HSE. The epidermis consisted of prolif-
erating keratinocytes within the basal layer, followed by multiple spinous layers, a granular layer, and cornified
layers. Within the TERT-HSE, the membrane junctions such as corneosomes, desmosomes, and hemidesmo-
somes were well developed as shown by ultrastructure pictures. Furthermore, the BM consisted of a lamina
lucida and lamina densa comparable to native skin. The dermal matrix of the TERT-HSE was more similar to
native skin than the primary construct, since collagen III, an ECM marker, was present in TERT-HSEs and
absent in primary HSEs. After wounding, the TERT-HSE was able to reepithelialize and secrete inflammatory
wound-healing mediators. In conclusion, the novel TERT-HSE, constructed entirely from human cell lines,
provides an excellent opportunity to study in vitro skin biology and can also be used for drug targeting and
testing new therapeutics, and ultimately, for incorporating into skin-on-a chip in the future.
Introduction
Human skin equivalents (HSEs) are important modelsfor fundamental research, for industry purposes (cyto-
toxicity studies, drug targeting, testing new therapeutics, and
treatment strategies) and for clinical applications. The need for
physiologically relevant HSE in vitro models is increasing,
since the EU regulations encourage replacement, reduction,
and refinement of animal models (EU Directive 2010/63/EU)
and since a banwas introduced for testing cosmetic ingredients
in animals (EU Cosmetic Directive 76/768/EEC; EU Cos-
metics Products Regulation [EC] No1223/2009; REACH
Regulation [EC] 1907/2006). Therefore, HSE in vitro models
are not only indispensable for classification and risk assess-
ment studies of chemicals (e.g., cytotoxicity, irritancy)1–5 but
they also offer a unique model to study normal and abnormal
skin biology, including wound healing, skin disease, and in-
fection. Examples of disease models include abnormal scar
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formation (e.g., keloid), melanoma invasion, psoriasis, and
skin blistering.3,6–13 HSEs are used for bacterial adhesion and
infection studies.12,14,15 In addition, HSEs are suitable for in-
vestigation of the effects of chemotherapeutics, drug delivery
of pharmaceuticals, photoprotective properties of various
compounds, and the xenobiotic metabolism.3,16–22
Developments over the last 30 years have led to HSEs being
constructed from primary cells, which very closely resemble
native skin. The epidermis, being the outermost layer of the
skin, forms an important barrier to pathogens and prevents
dehydration. Renewal of the epidermis is a continuous, tightly
regulated differentiation process. In HSEs, similar to native
skin, proliferation is strictly regulated by the keratinocytes of
the basal layer. In native human skin, the proliferation rate
within the stratum basale (SB) is 10–12%, as shown by the
Ki67 protein expression.23 When keratinocytes make a com-
mitment to terminally differentiate, they migrate from the basal
layer to form the suprabasal layers.23–26 The epidermal cells
undergo several morphological and biochemical changes
leading to the following structural layers: the basal layer, spi-
nous layer, granular layer, and cornified layer. Each epidermal
layer is characterized by the production of their specific epi-
dermal differentiation proteins. The cuboidal-shaped cells of
SB express keratin 5 and 14 (K5/K14), whereas the suprabasal
spinous layers produce keratin 1 and keratin 10 (K1/K10). The
epidermal cells in the stratum granulosum (SG) stop to syn-
thesize keratins and start with the production of late epidermal
differentiation proteins (e.g., involucrin, loricrin, and filaggrin).
The final stage of keratinocyte terminal differentiation involves
formation of the cornified envelope known as the stratum
corneum (SC). When the skin becomes damaged or during
skin disease (e.g., wounding, psoriasis), the expression of a
stress-related hyperproliferative marker, keratin 6 (K6), is in-
creased in all layers of the epidermis.23,27,28 Hypertrophic scar
formation is associated with increased alpha-smooth muscle
actin (a-SMA) expression.10
The membrane junctions, which interconnect keratino-
cytes within the SB, stratum spinosum (SS), and SG, are
called desmosomes.29 At the interface of the SG and SC,
desmosomes transform into corneosomes.30 Malformation
of desmosomes might lead to blistering diseases.31–33
The epidermis is attached to the basement membrane
(BM), which is situated between the epidermis and dermis.
The BM can be divided into a lamina lucida and lamina
densa. It anchors the epithelial cells to the dermal matrix
with hemidesmosomes and functions as a mechanical bar-
rier. The hallmark of the BM is the expression of laminin 5
and collagen IV.34 The dermis consists mainly of connective
tissue and is responsible for elasticity and tensile strength of
the skin. The main cell type found within the dermis is the
spindle-shaped fibroblast, which is positive for the mesen-
chymal vimentin marker and communicates extensively
with keratinocytes within the epidermis, leading to synthesis
of the extracellular BM and dermal matrix. The dermal
extracellular matrix (ECM) is predominantly characterized
by elastin, fibronectin, and multiple types of collagen.
Maintenance and restoration of the skin homeostasis is also
established by interaction between the dermal fibroblasts
and epidermal keratinocytes, which secrete a cocktail of
cytokines, chemokines, and growth factors.9,35–38
The currently existing HSEs are generally constructed of
primary human skin cells, which originate from freshly isolated
healthy human skin obtained from standard surgical procedures.
The production is limited by the following: (i) logistical issues
concerning restricted supply of fresh, healthy donor skin, (ii)
donor variation, and (iii) restricted proliferation and amplifica-
tion capacity of primary cells. The use of physiologically rele-
vant human skin cell lines, for example, hTERT-immortalized
keratinocytes and fibroblasts, will overcome these limitations
and provide the possibility for higher throughput screening of
new products and newdrugs. However, it should be realized that
donor variation is sometimes required to accurately resemble
the population and this should not be forgotten when using cell
lines. In addition, the ethical issues for obtaining the donor tissue
for modification still exist, but are now limited to a single donor,
rather than many donors, due to immortalization of the cells. In
recent years, several researchers have developed HSEs, which
incorporate keratinocyte cell lines for the epidermal component;
however, for the dermal compartment, they used human pri-
mary fibroblasts, human fetal lung fibroblasts (MRC5), or 3T3
mouse fibroblasts.39–53 At the moment, to the best of our
knowledge, there are no full-thickness skin equivalents (SEs)
available, which completely consist entirely out of physiologi-
cally relevant human skin cell lines.
Immortalization with hTERT cDNA will overcome cell
senescence of primary cells. During each normal cell divi-
sion, the telomeres of primary cells are shortened. The exo-
genous hTERT cDNA, which encodes for the catalytic
subunit of human telomerase, prevents telomere shorten-
ing and, thereby, increases the life span of the cells, while
maintaining the normal physiology and phenotypic prop-
erties of the cells.54,55
In our study, we determined whether hTERT-immortal-
ized human newborn foreskin keratinocytes with spontane-
ous loss of p16 expression (N/TERT-1)50 are suitable for
reconstructing a fully differentiated epidermis in combina-
tion with hTERT-immortalized human newborn foreskin
fibroblasts (BJ-5ta), which are incorporated into the dermal
compartment of the SE. Both cell lines retained their normal
morphology and proliferation rate in the two-dimensional
culture.50,56 The aim of our study was to develop a fully
differentiated HSE constructed entirely from human skin
TERT-immortalized cell lines, which resembles native
human skin and would be applicable for a broad range of
in vitro skin studies. The TERT-HSE was intensively
characterized at the histological level (hematoxylin and
eosin [H&E] staining and immunohistochemistry of epi-
dermal and dermal markers) and ultrastructural level (elec-
tron microscopy [EM]). In addition, the protein secretome
(cytokines, chemokines, and growth factors) was analyzed
by ELISA. Finally, as proof-of-concept for functionality, the
TERT-HSE was compared with our in vitro wound-healing
model, in which primary cells are currently used.9
Materials and Methods
Cell culture of human primary cells and
TERT-immortalized keratinocytes and fibroblasts
Primary human epidermal keratinocytes were isolated
from neonatal foreskin as described earlier.57 Both primary
keratinocytes and N/TERT-1 keratinocytes50 were cultured
in Dulbecco’s modified Eagle’s medium (DMEM)/Ham’s
F12 (3:1) (Gibco), 50mg/mL gentamycin (Centrafarm), 1%
UltroserG (UG) (Bio Sepra SA), 1 mM hydrocortisone,
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0.1 mM insulin, 1 mM isoproterenol, 2 ng/mL KGF at 37C,
and 7.5% CO2 (primary) or 5% CO2 (cell line). The culture
medium was renewed twice per week. Cultures with 70–
80% confluency were used for the construction of HSEs.
N/TERT-1 was provided by Rheinwald and the Cell Culture
Core of Harvard Skin Disease Research Center.
Primary human dermal fibroblasts were isolated from
neonatal foreskin as described earlier.58 Both primary der-
mal fibroblasts and hTERT BJ-5ta fibroblasts (ATCC, LGC
Standards GmbH) were cultured within DMEM (Gibco), 1%
UG, and an antibiotic (50 mg/mL gentamycin for primary
fibroblasts and 0.01mg/mL hygromycin for hTERT BJ-5ta
fibroblasts) at 37C and 5% CO2. Culture medium was re-
newed twice per week. Cultures with 70–80% confluency
were used for the construction of HSEs. Culture additives
were obtained from Sigma-Aldrich, unless otherwise stated.
Human skin equivalent
The HSE was constructed as described earlier.10 Briefly,
the primary or cell line fibroblasts (4· 105 cells) were seeded
onto a bovine matrix without a BM (2.2· 2.2 cm2) (Ma-
triDerm, Med Skin Solutions Dr. Suwelack AG). This matrix
consists of collagen types I, III, and V, and elastin. It does not
show cross-reactivity with human IHC antibodies, except for
collagen I and elastin. These fibroblast sheets were cultured
submerged for 3 weeks in the fibroblast sheet medium
(DMEM/Ham’s F12 [3:1], 50mg/mL gentamycin, 2% UG,
5mg/mL insulin, 50mg/mL ascorbic acid (Sigma), and 5 ng/
mL epidermal growth factor). After 3 weeks, the primary or
cell line keratinocytes (5· 105 cells) were seeded onto the
matrices populated with the corresponding primary or cell
line fibroblasts. After 4 h of attachment, the cultures were
placed submerged for 3–4 days within DMEM/Ham’s F-12
(3:1), 1% UG, 50mg/mL gentamycin, 1mM hydrocortisone,
1mM isoproterenol, 0.1mM insulin, and 2 ng/mL KGF;
thereafter, the cultures were placed air-exposed for 14 days in
DMEM/Ham’s F-12 (3:1), 0.2% UG, 50mg/mL gentamycin,
1mM hydrocortisone, 1mM isoproterenol, 0.1mM insulin,
10mM l-carnitine, 10mM l-serine, 1mM dl-a-tocopherol
acetate, and enriched with a lipid supplement containing
25mM palmitic acid, 15mM linoleic acid, 7mM arachidonic
acid, and 24mM bovine serum albumin. The culture medium
was refreshed twice a week. Finally, the HSEs were harvested
for histological analysis (H&E, IHC, and EM), and a 24-h
supernatant was collected for ELISA.
Burn and cold injuries
Burn injury or cold injury was applied to the TERT-HSEs
after *2 weeks of air-exposed culture as described previ-
ously.9 Times and temperatures for obtaining full-thickness
injury were optimized by heating cultures for different du-
rations and time periods followed by histological examina-
tion 1 day after injury before finalizing the protocol (data
not shown). For full-thickness burn injury, a metal device
(tip with a length of 2 cm and a width of 2mm) attached to a
Weller soldering station (WSD81 Cooper Tools), heated
continuously at 117C, was applied for 10 s to the SC of the
TERT-HSEs. Cold injuries were applied with a metal device
with similar dimensions as the burn injury device. This
device was cooled down to -196C in liquid nitrogen and
directly applied with gentle pressure to the SC for 10 s. After
wounding, TERT-HSEs continued air-exposed culture.
Wound closure and soluble mediator secretion were ana-
lyzed at day 1, 3, and 7 after wounding. HSEs were given
new culture media 24 h before collecting the supernatant for
soluble mediator analysis at each time interval.
Morphology, immunohistochemistry, and ultrastructure
For histological analysis, the HSEs of three independent
experiments (e.g., primary cells: three different donors; cell
lines: three different passages) were fixed within 4% form-
aldehyde and embedded in paraffin. Paraffin sections (5 mm)
were cut and used for H&E or IHC staining. The antibodies
for IHC are summarized in Table 1 and were used in
combination with EnVision (Dako) followed by the AEC
substrate to visualize the specific antibody. Brightfield
photographs (100- and 200-fold magnification) were made
with a Nikon microscope, a digital camera, and NIS
Table 1. Primary Antibodies Used for Immunohistochemical Staining
Antibody Dilution Isotype Material Antigen retrieval Company
Collagen IV 1:20 IgG2b Paraffin Citrate buffer,a Pepsinb Monosan
Involucrin 1:1200 IgG1 Paraffin — Novocastra
Keratin 5 1:150 IgG1 Paraffin Citrate buffer,a Pepsinb Monosan
Keratin 6 1:150 IgG1 Paraffin Citrate buffera Progen Biotechnik GmbH
Keratin 10 1:500 IgG1 Paraffin Citrate buffer,a Pepsinb ICN Biomedicals
Ki67 1:50 IgG1 Paraffin Citrate bufferc Dako
Loricrin 1:1200 Rabbit serum Paraffin — Covance
Vimentin 1:200 IgG1 Paraffin Citrate buffera Dako
Collagen III 1:2400 IgG1 Paraffin Citrate buffer,a Pepsinb Abcam
Fibronectin 1:1000 IgG1 Frozen — Santa-Cruz Biotechnology
Laminin 5 1:400 IgG2a Frozen — Dako
Alpha-smooth
muscle actin
1:4000 IgG2a Paraffin — Dako
aThe slides were heated at 100C in 0.01M citrate buffer (pH 6.0) in a microwave and cooled to room temperature for at least 2 h before
adding the antibody.
bAfter antigen retrieval, the slides were incubated with 4mg/mL pepsin in 0.2N HCl for 15min.
cThe slides were heated at 100C in 0.01M citrate buffer (pH 6.0) on a cooker for 30min and cooled to room temperature for at least 2 h
before adding the antibody.
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Elements AR version 2.10 software (Nikon Instruments
Europe B.V.). The proliferation index is expressed as the
number of Ki67 positively stained nuclei divided by the total
number of basal epidermal cells ·100%, as described ear-
lier.23 Reepithelialization was defined as the distance that
the newly formed epidermis had migrated into the wound
bed and was measured with NIS Elements.
The ultrastructure was determined with EM. Native skin,
primary HSEs, and TERT-HSEs were regularly fixed in 4%
glutaraldehyde in 0.1M sodium cacodylate pH 7.4, post-
fixated with 1% osmium tetroxide in 1.5% potassium fer-
ricyanide (K3[Fe(CN)6]) in 0.1M sodium cacodylate pH 7.4,
and embedded in the EPON resin. The 70-nm sections were
imaged at the Philips CM100 EM or the Zeiss Supra 55 EM.
Enzyme-linked immunosorbent assay
Protein secretion levels within the 24-h supernatant
samples collected from primary HSEs and TERT-HSEs
were determined with the enzyme-linked immunosorbent
assay (ELISA), as described earlier by Spiekstra et al.37
Results are expressed as pg/mL/24 h or ng/mL/24 h. ELISA
reagents were used for chemokine, cytokine, and growth
factor quantification in accordance to the manufacturer’s
specifications. All antibodies were supplied by R&D Sys-
tems, Inc., except for CXCL-8/IL-8 and TNF-a, PeliPair
reagent sets, supplied by Sanquin.
Statistics
Statistical analysis was performed with the aid of Graph-
Pad Prism, version 6 (GraphPad Software, Inc.). Specific
details of the statistic tests are mentioned in the legends.
Differences were considered significant when p< 0.05.
Results
Human TERT-immortalized cell line SE resembles
native skin
Histological analysis demonstrated that the TERT-HSEs
retained the morphological characteristics of normal, native
human skin and were comparable to our in-house primary
HSEs. The TERT-HSEs showed a well-defined epidermis
on top of a fibroblast-populated matrix. The epidermis
consisted of an SB, a multilayered SS, SG, and SC (Fig. 1).
The Ki67 proliferation index of the cells in the SB of TERT-
FIG. 1. Histological ap-
pearance of primary and
TERT-immortalized cell line
SEs resembles native skin.
Characterization of 2-week
air-exposed reconstructed
HSEs, which were developed
with human primary or hu-
man TERT-immortalized
keratinocytes and fibroblasts.
Histology of native skin and
the different SEs is shown
with a hematoxylin and eosin
staining and immunohisto-
chemical stainings using an-
tibodies directed against
human vimentin (fibroblasts),
laminin 5, collagen IV
(basement membrane: lamina
lucida and lamina densa, re-
spectively), and Ki67 (pro-
liferation index). Stainings
were performed on represen-
tative HSEs derived from
three independent culture
experiments. Scale bar rep-
resents 50 mm. HSEs, human
skin equivalents; SEs, skin
equivalents. Color images
available online at www
.liebertpub.com/tea
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HSEs (14.5%– 2.7%, mean – SD, n = 7) was comparable to
primary HSEs (13.5%– 4.4%, mean – SD, n= 7) (Fig. 1) and
closely resembled our previously reported proliferation rate
of native skin (10–12%).23 The TERT-HSEs as well as
primary HSEs showed vimentin-positive fibroblasts in the
dermis similar to native skin (Fig. 1). As in native skin, the
TERT-HSEs showed expression of the BM proteins, laminin
5 (lamina lucida) and collagen IV (lamina densa), which
were located at the interface of the collagen–elastin matrix
and the epidermis. The collagen IV expression was more
pronounced in TERT-HSEs compared to primary HSEs (Fig.
1). The BM markers were absent in the original collagen–
elastin matrix, which was used as the dermal component
(data not shown).
Next, the protein expression of epidermal differentiation
markers was examined. As in native skin and primary
HSEs, K5 was predominantly located within the cuboidal
epidermal cells of the SB and lower spinous layers and
K10 was expressed in all suprabasal epidermal layers of
the TERT-HSEs (Fig. 2). Positive IHC staining for the
cornified envelope precursor involucrin was observed in
the upper layers of the SS and predominantly in the SG,
FIG. 2. Epidermal differ-
entiation and dermal matrix
markers within 2-week air-




dermal matrix markers on
native skin, primary, and cell
line HSE sections are shown.
Markers represent different
stages of epidermal differen-
tiation: for example, early
(keratin 5), intermediate
(keratin 10 and involucrin),
and late (loricrin) epidermal
differentiation. Keratin 6 is a
hyperproliferative marker.
Collagen III is a component
of the dermal ECM. Alpha-
smooth muscle actin is a
myofibroblast marker and is
associated with scar forma-
tion. Stainings were per-
formed on representative
HSEs derived from three in-
dependent culture experi-
ments. Scale bar represents
50 mm (upper epidermal
panels) or 100 mm (dermal
panels). ECM, extracellular
matrix. Color images avail-
able online at www
.liebertpub.com/tea
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and loricrin, the late terminal differentiation marker, was
observed in the SG of the TERT-HSEs, which was com-
parable with the expression pattern of involucrin and lor-
icrin within native skin as well as primary HSEs (Fig. 2).
The hyperproliferative marker K6 was absent in native skin
and primary and TERT-HSEs (Fig. 2).
In addition, collagen III, a native ECM marker, was ex-
pressed within the dermal compartment of TERT-HSEs with
the TERT fibroblasts, whereas it was absent in primary
HSEs (Fig. 2). However, fibronectin, another ECM marker,
was present in the dermis of both primary as well as TERT-
HSEs (data not shown). Intermittent a-SMA staining, re-
presenting sporadic myofibroblasts, was randomly present in
the dermal matrix of TERT-HSEs, whereas it was located
directly underneath the BM within primary HSEs (Fig. 2).
The EM pictures showed that the ultrastructure of TERT-
HSEs was comparable to native skin (Fig. 3) and primary
HSEs (not shown). The TERT-HSEs presented well-stratified
epithelial layers on top of a fibroblast-populated dermal ma-
trix with collagen bundles confirming the H&E and IHC re-
sults. The SC consisted of multiple cornified layers connected
with corneosomes. The SG and SS presented multiple
FIG. 3. Ultrastructure of
TERT-immortalized cell line
SEs resembles native skin.
Ultrastructure pictures of na-
tive skin (left column) and cell
line HSE (middle and right
column [detail of white
square; fourfold]). EM over-
view picture of the epidermis
of native skin and TERT-
HSE. Fibroblasts are located
in between the collagen bun-
dles of the dermal matrix
(ECM). Corneosomes (small
arrows) are present within the
SC and at the SG/SC inter-
face. Desmosomes (large ar-
rows) are depicted within the
SG, SS, and SB. Hemi-
desmosomes (arrow heads) at
the bottom of the SB attaching
the epidermis to dermis.
Basement membrane contains
a lamina lucida (*) and lamina
densa (B). SC, stratum cor-
neum; SG, stratum granulo-
sum; SS, stratum spinosum;
SB, stratum basale; Ker, ker-
atinocyte; Fib, fibroblast.
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desmosomes within the cell membrane of the keratinocytes.
The intracellular space between the keratinocytes within the
SS was smaller compared to the intracellular space of the
cuboidal keratinocytes in the SB. Multiple hemidesmosomes
were present at the lower side of the SB and anchored the
epidermal cells to the ECM. The BM clearly showed a lamina
lucida and lamina densa (Fig. 3), developed within 2 weeks of
air-exposed culture time. Along the BM we observed some
exocytose-like vacuoles in both cell line and primary HSEs,
and native skin. The presence of mitochondria referred to a
healthy status of the tissue.
In conclusion, extensive morphological characterization
shows that the HSE constructed entirely from the TERT-
immortalized human skin keratinocyte and fibroblast cell
lines closely resembles normal, native human skin. A fully
differentiated epidermis is well formed on a fibroblast-
populated dermis, which is very similar to our HSE con-
structed from primary skin cells that are not immortalized.
Human TERT-immortalized cell line SE secretes
cytokines and chemokines
Since the skin continuously secretes basal levels of cy-
tokines, chemokines, and growth factors to maintain skin
homeostasis, we determined the basal secretion of these
factors within the culture supernatant of the TERT-HSE
during a 24-h period and compared these secretion profiles
with the secretome of freshly excised ex vivo skin37 and
primary HSEs. Three groups of proteins could be distin-
guished by ELISA (Table 2). In the first group (TERT-
HSE = ex vivo skin), chemokines, CXCL-8/IL-8 and CCL-5/
RANTES, and TIMP-2 secretion from TERT-HSEs were
similar to ex vivo skin. Cytokines, TNF-a and IL-1a, were
low or undetectable in both. In the second group (TERT-
HSE > ex vivo skin), inflammatory/angiogenic mediator se-
cretion of CXCL-1/GRO-a and CCL-2/MCP-1 was more
prominent within TERT-HSEs compared to ex vivo skin. In
the third group (TERT-HSE < ex vivo skin), cytokine IL-6
and growth factor, VEGF and HGF, secretion was more
abundant in the supernatant of ex vivo skin compared to the
TERT-HSE supernatant. Indeed, VEGF and HGF secretion
was below the detection limit of the ELISA in TERT-HSEs.
Comparison of the primary HSE protein profiles to the
ex vivo skin protein profiles resulted in a similar secretion
profile as the TERT-HSE versus ex vivo skin, except for
CXCL-8/IL-8 and CCL-5/RANTES secretion, which was
similar between TERT-HSE and ex vivo skin. However,
CXCL-8/IL-8 and CCL-5/RANTES secretion was signifi-
cantly increased within primary HSEs compared to ex vivo
skin (Table 2). Furthermore, when comparing primary
HSEs with TERT-HSEs, secretion of CXCL-1/GRO-a, CCL-
2/MCP-1, VEGF, and HGF was more abundant in primary
HSEs compared to TERT-HSEs (Table 2). In conclusion, the
TERT-HSE is able to secrete a broad panel of cytokines and
chemokines, which is more characteristic for adult ex vivo
skin than primary foreskin HSE obtained from juveniles.
Human TERT-immortalized cell line SE shows
inflammatory cytokine and chemokine secretion
during wound closure
Previously, we have shown that primary HSEs can be used
to study inflammatory mediator release during wound heal-
ing.9 Therefore, burn and cold injuries were made within the
TERT-HSE cultures to test the wound-healing capacity of the
immortalized cell line three-dimensional (3D) model. Re-
epithelialization and secretion of (pro)inflammatory media-
tors into the supernatant were investigated at 1, 3, and 7 days
after wounding. Wound healing was already apparent 1 day
after injury, with reepithelialization being slightly more en-
hanced 1 day after cold injury compared to burn injury (Fig.
4A, B). Ingrowth after wounding was a continuous process
with almost complete reepithelialization resulting in a well-
differentiated epidermis after 7 days (Fig. 4C, D).
Table 2. Basal Levels of Wound-Healing Mediator Secretion
under Homeostatic Conditions (pg/mL/24 h)







Group 1: TERT-HSE = ex vivo skin
CXCL-8/IL-8 Proinflam; Ang; Epith 22.655– 12.774 78.800– 8.938b,2 19.647 – 13.512
CCL-5/RANTES Inflam 108– 16 191– 18b,1 83 – 40
TIMP-2 TR; Epith 35.010– 5.846 53.889– 8.778 38.355 – 32.576
TNF-a Proinflam nd nd nd
IL-1a Proinflam nd nd 22 – 15
Group 2: TERT-HSE > ex vivo skin
CXCL-1/GRO-a Inflam; Ang; Epith 35.439– 17.009 421.172– 44.395d,4 3.109 – 1.689
CCL-2/MCP-1 Inflam; Ang; Epith; TR 15.945– 7.442 69.153– 12.190c,3 1.497 – 1.124
Group 3: TERT-HSE < ex vivo skin
IL-6 Proinflam; Gran; Ang 568– 315a 3.638 – 873a 131.756 – 64.057
VEGF Ang nd 522– 41a 2.425 – 499
HGF TR; Epith; Gran; Ang nd 2.330 – 203b 6.227 – 4.209
Statistical analysis: comparison of TERT-HSE or primary HSE with ex vivo skin; one-way ANOVA, Bonferroni’s multiple comparison
tests or unpaired t-test (a,1p < 0.05; b,2p < 0.01; c,3p < 0.001; d,4p< 0.0001; a–d comparison between TERT-HSE or primary HSE and ex vivo
skin; 1–4comparison between TERT-HSE and primary HSE).
*Ex vivo skin data are adapted from Spiekstra et al.37
Ang, angiogenic; Epith, epithelialization; Gran, granulation tissue stimulating; HSE, human skin equivalent; Inflam, inflammatory
chemokine for lymphocytes, neutrophils, and/or macrophages; nd: below detection limit; Proinflam, proinflammatory; TR, tissue remodeling.
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(Pro)inflammatory cytokine and chemokine secretion is
related to the inflammatory phase of wound healing.59–61
Cytokines and chemokines (IL-1a, IL-6, CCL-20, CXCL-
8/IL-8, and CXCL-1/GRO-a) showed a rapid increase
during the first 24 h after burn or cold injury followed by a
decrease toward homeostatic levels within the period
thereafter (Fig. 4E). In contrast, the inflammatory chemo-
kine CCL-5/RANTES secretion increased steadily during
the 7-day study period after burn or cold injury (trend)
within TERT-HSEs (Fig. 4E). No significant differences in
cytokine or chemokine profiles were observed between
burn and cold injury-inflicted wounds within TERT-HSEs
(Fig. 4E).
Taken together, our results show that the TERT-HSE,
based on TERT-immortalized keratinocytes and fibroblasts,
not only closely resembles the morphology and proliferation
rate of normal, native human skin but also secretes a mixture
of cytokines and chemokines similar to native excised skin.
In addition, the TERT-HSE is able to respond to environ-
mental assault (wounding) in a similar way to primary HSE9
FIG. 4. Reepithelialization
and protein secretion of
wound-healing mediators
after burn and cold injury in
cell line SEs. Representative
hematoxylin and eosin stain-
ing of epidermal ingrowth
within TERT-HSEs after
burn injury (A) and cold in-
jury (B) 1 day after wound-
ing. The large arrow
represents the direction of the
migrating epidermal front,
and the small arrows indicate
the start and the end of the
epidermal ingrowth. Com-
plete closure after burn (C)
or cold (D) injury is shown 7
days after injury. Scale bar
represents 100 mm. (E) Se-





(gray bars) or cold (black
bars) injury during time.
White bar represents un-
wounded baseline secretion
over 24 h. Time period 0–1
represents supernatant har-
vested during the first 24 h
after wounding, time periods
2–3 and 6–7 represent su-
pernatant collected during
24 h from day 2 to day 3 or
day 6 until day 7 after
wounding, respectively.
Each bar represents the
mean – SD of four to five
independent experiments.
Statistical analysis: Kruskal–
Wallis test followed by
Dunn’s multiple comparisons
test; *p < 0.05; **p < 0.01.
Color images available online
at www.liebertpub.com/tea
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and most importantly to native skin,60 with regard to re-
epithelialization and secretion of inflammatory mediators.
Discussion
In this study, we successfully developed a functional
full-thickness tissue-engineered SE entirely from human
TERT-immortalized cell lines. The TERT-HSE consists of a
well-differentiated epidermis on top of a fibroblast-popu-
lated dermis and closely resembles the morphology of native
skin and primary HSE. The TERT-HSE has a normal pro-
liferation rate within basal layer keratinocytes. The skin
construct secretes a cocktail of cytokines and chemokines
related to skin homeostasis and inflammation. Stress-related
signs are absent during culturing of the construct, since the
hyperproliferative marker, K6, is absent. The advantages of
this well-defined cell line in vitro skin model above the use
of freshly isolated primary skin cells are the continuous
supply of easily amplified cells, no donor variation, and no
logistical (transport from the clinic to laboratory) and ethical
issues. With the effective proof-of-concept wound-healing
model, we show that the TERT-HSE is functional. It has the
potential to be an important tool to study the skin physi-
ology and multiple other applications, and may contribute to
the replacement, reduction, and refinement of animal models
in the future.
To our knowledge, this is the first study that describes a full-
thickness in vitro skin model, in which both the epidermal and
dermal compartment are constructed entirely from immortal-
ized cell lines. Previously, the TERT-immortalized keratino-
cyte cell line was used to construct a full-thickness SE, in
which primary fibroblasts were seeded into the dermal com-
partment.39,40,50,53 In line with our model, the TERT-immor-
talized keratinocytes differentiated excellently. Other
keratinocyte cell lines, which have been used for the con-
struction of the epidermal component of a 3D-organotypic
skin culture, are HaCaT-, NIKS-, HPV-16-, and HPV-18-
immortalized keratinocytes, Cdk4-overexpressing keratino-
cytes, and Y-27632 (Rho kinase inhibitor)-immortalized
keratinocytes. However, the dermal counterpart of these con-
structs contained human dermal fibroblasts or 3T3 feeder
mouse fibroblasts.41,42,44,46,48,49,51,52,62–66 Unfortunately, the
HaCaT HSEs showed deficiencies in epidermal differentiation
and stratification depending on the culture conditions64,65 and
the HPV HSEs displayed a disorganized epidermal layer.41
The barrier function is one of the main functions of
human skin and an important feature, for example, drug
targeting studies. It effectively protects against foreign
substances/pathogens and prevents dehydration. The SC is a
key component of the barrier structure. Our EM pictures
showed a well-developed multilayered SC with corneo-
somes interconnecting the layers. Together with the findings
of Van Drongelen et al., who showed that SEs made of
TERT keratinocytes and primary fibroblasts exhibit a sim-
ilar lipid organization and permeability as the SC of primary
HSEs, and few differences in lipid composition,53 we sug-
gest that the TERT-HSEs do have a barrier capacity that is
mimicking the native skin.67
Desmosomes, which are located in the cell membrane,
interconnect the keratinocytes.29 They provide strength to
the skin to withstand movements. Malformation of desmo-
somes could lead to blister diseases.28,31,32 Our TERT-HSEs
exhibit well-developed desmosomes within the SG, SS, and
SB, giving strength to the construct.
For the development of the BM, cross talk through
paracrine signaling between the keratinocytes and fibro-
blasts is necessary.34,35,68 Our TERT-HSEs showed ex-
pression of the BM proteins, laminin 5 (lamina lucida) and
collagen IV (lamina densa), which was located at the in-
terface of the epidermis and the dermal collagen–elastin
(bovine) matrix. This was confirmed by EM, where the
presence of a lamina lucida and lamina densa was shown
and in addition the presence of hemidesmosomes, which
connect the epidermis to the ECM. Therefore, we can
conclude that paracrine signaling between TERT-immor-
talized keratinocytes and fibroblasts occurs in our model,
resulting in the construction of a well-developed BM with
hemidesmosomes within 2 weeks. Since the BM is present
in the TERT-HSEs, we expect to have a well-anchored
epidermis to the dermis and a mechanical barrier, which is
comparable to native skin.
Within the dermis, the TERT-HSEs exhibited the ECM
markers, collagen III, and fibronectin, like native skin,
whereas the primary construct lacked the collagen III protein.
Thus, the TERT keratinocyte and fibroblast cross talk results
in the production of collagen III, whereas primary keratino-
cytes and fibroblasts are not capable to produce collagen III.
The observed amount of a-SMA-positive cells within the
TERT-HSEs is comparable to primary HSEs and the previous
results of van den Broek et al.10 In conclusion, the TERT-
HSEs do not exhibit signs of hypertrophic scarring.
Overall, the TERT-HSE closely resembles the structure
and composition of native skin.
For regulation of normal skin homeostasis and in re-
sponse to environmental stimuli (danger), the secretion of
cytokines, chemokines, and growth factors is essen-
tial.9,37,60,61 In this study, we showed that the secretome of
the TERT-HSE consists of a cocktail of many cytokines and
chemokines. Interestingly, the secretome of the TERT-HSE
more closely resembles that of adult excised skin than pri-
mary HSE in general. However, the growth factors, VEGF
and HGF, were not detectable in the supernatant of TERT-
HSEs, whereas they were secreted into the supernatant of ex
vivo skin and primary HSEs. This might be partly explained
by the presence of endothelial cells and other cell types
within the excised skin. However, TERT fibroblasts cultured
in the absence of TERT keratinocytes did secrete low
amounts of VEGF and HGF (data not shown), indicating
that, possibly, uptake is occurring from the culture super-
natant in the TERT-HSE model.
As a proof-of-principle for functionality, we demon-
strated that the TERT-HSE provides a powerful tool to study
wound healing in vitro. In native skin, two processes occur
parallel after wounding, for example, secretion of multiple
inflammatory mediators, which regulate infiltration of neu-
trophils, macrophages, and lymphocytes into the wound bed,
and reepithelialization to close the wound. Upon wounding,
our TERT-HSE showed an increase of a broad panel of
inflammatory cytokines and chemokines within 24 h in re-
sponse to cellular damage, mimicking the acute inflamma-
tory phase of in vivo wound healing.60,61 This finding was
similar to our earlier findings with primary in vitro HSE,
except for CXCL-1/GRO-a, which showed an increase di-
rectly after injury and remained elevated in primary HSEs.9
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Burn injuries repair with more (hypertrophic) scar for-
mation compared to cold injuries in vivo. In cold injuries,
our cell line in vitro skin model equivalent showed a faster
reepithelialization directly after wounding compared to burn
wounds. A similar phenomenon was observed in the primary
HSEs, where they hypothesized that within cold injuries the
BM is still intact, whereas within a burn wound the BM
proteins are denatured.9 Despite the morphological differ-
ences concerning the epithelial ingrowth at day 1 between
the freeze and the burn wounds, no significant differences
with respect to the secretome were determined between the
different wound types in the cell line model, similar to the
observations in the primary model.9 Thus, the TERT-HSE is
able to produce wound-healing mediators, which are nec-
essary for wound closure, and is able to restore the epider-
mis after different types of injury by cross talk through the
TERT keratinocytes and fibroblasts.
In conclusion, in this study, we describe the first physi-
ologically relevant full-thickness human SE constructed
entirely from cell lines. The use of these cells enables
scaling up for human SE production, creates less logistical
hurdles, and eliminates the influence of donor variation.
Therefore, this SE model provides an excellent opportunity
to study in vitro skin biology and can also be used for drug
targeting and testing new therapeutics and, ultimately, for
incorporating into skin-on-a chip in the future.13
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